Events

Do you have a project in need of funding? Are you interested in learning about engaging with industry partners?

James Bellush, Manager of Scientific Scouting, will be hosting weekly virtual office hours, every Friday from 11 a.m. to 1 p.m. to help Weill Cornell investigators support their ongoing translational research projects through industry sponsored research collaborations and grants.

Please use the link here to schedule your private meeting with James. Questions? Email james.bellush@cornell.edu.

Building a startup means understanding your legal obligations as an employer from day one. 

 Join us for an Entrepreneurship Essentials workshop focused on worker’s compensation, where we’ll break down what founders need to know to protect their teams and their businesses. This session will cover when coverage is required, how policies work, common misconceptions, and what steps to take if a workplace injury occurs. 

Whether you’re preparing to hire your first employee or already growing your team, this workshop will provide practical guidance to help you stay compliant, minimize risk, and build a strong operational foundation. 

RSVP today to ensure your startup is set up for success! 

Why does health IT still frustrate so many healthcare stakeholders? Why were early systems designed with limited clinician input? Can AI help fix the problems created by legacy systems?

You’re invited to join us for a conversation with Dr. S. Yin Ho, author of Rushing Headlong: Health IT’s Legacy and the Road to Responsible AI. 

In her new book, Dr. Ho examines how the early architecture of health information technology shaped the systems that clinicians and researchers struggle with today. As generative AI arrives, those same structural choices may determine whether AI ultimately better serves practitioners and patients or simply adds another layer of complexity.

Dr. Ho is a serial entrepreneur and visionary executive in health IT and clinical research with more than 25 years of experience founding, building, and leading healthcare technology companies and initiatives.  Most recently, she served as Interim CEO of Veradigm, where she led the strategic acquisition of generative AI company ScienceIO. Under her leadership, Veradigm became the first electronic health record company to develop proprietary small language models in-house—an effort aimed at improving the quality of clinical data used for both care and research.

Join us for a candid discussion about the past, present, and future of health IT.  Register here.

During this webinar, we will explore the role of business development and partnering in helping advance life sciences innovation from the lab to the marketplace. Through a discussion with our seasoned panelists, we will compare the business development objectives and strategies across different ecosystem partners (venture capital, biotech and pharma) and the role (and goals) of academic partnerships.

Register here. 

Ready to bring your product idea to life? – Apply Now. 

The final application deadline is midnight (ET) on March 22, 2026. 

Over 10 weeks, Rev’s Prototyping Hardware Accelerator offers four tracks – Classic, AgTech, ClimateTech and MedTech - to guide product teams to determine if their ideas are commercially desirable, technologically feasible and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Register for an upcoming information session to have your questions answered by program leadership: 

• Thursday, February 19, 2026 from 5 – 6 PM ET 
• Tuesday, March 10, 2026 from 6 – 7 PM ET 

Questions about the program can be directed to rev@revithaca.com.   

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project in a one-on-one meeting with a business development and licensing professional. The March office hours will be hosted by Brian Kelly, Ph.D., CLP, director of business development and licensing. 

Brian manages a portfolio of inventions focusing on oncology, gene therapy, metabolic diseases, the microbiome and endocrine disorders. Prior to joining CTL at Weill Cornell, he served as director of intellectual property for New York University’s tech transfer office. He has also held positions at the University of Minnesota as a licensing associate, Heide, Hyde & O’Donnell as an associate European patent attorney and Smith, Kline & French as a research chemist.

Register here for your 30-minute private session. 

The BenDaniel Venture Challenge (BVC) is Big Red Venture’s Annual Pitch Competition. BRV will select five finalists to pitch their business ideas to a panel of investors during Entrepreneurship at Cornell Celebration on April 10. Winners will earn a cash prize totaling $25,000! Companies based in New York state or with a Cornell affiliation are eligible to apply. Big Red Ventures (BRV), Cornell’s early-stage venture capital fund, operated entirely by a team of MBA students, runs this competition each year, in partnership with Entrepreneurship at Cornell.

Application Deadline March 14th. Apply Here.

Biotech entrepreneurship sits at the intersection of science, innovation, and real-world impact. Join us for an engaging fireside chat with Sasank Vemulapati, co-founder of LoBio, to learn what it’s really like to build a company in this space.  

You’ll hear firsthand insights on launching a startup, navigating early challenges, and turning an idea into a growing venture. Sasank will share his experience in biotech entrepreneurship, including lessons learned from founding a startup and advice for aspiring entrepreneurs. 

Register here. 

Over 10 weeks, Rev’s Prototyping Hardware Accelerator offers four tracks – Classic, AgTech, ClimateTech and MedTech - to guide product teams to determine if their ideas are commercially desirable, technologically feasible and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Register for an upcoming information session to have your questions answered by program leadership: 

• Thursday, February 19, 2026 from 5 – 6 PM ET 
• Tuesday, March 10, 2026 from 6 – 7 PM ET 

Ready to bring your product idea to life? – Apply Now. The final application deadline is midnight (ET) on March 22, 2026. Questions about the program can be directed to rev@revithaca.com.   

You are invited to join an upcoming panel highlighting emerging innovations at the intersection of neurotechnology, rehabilitation, and data-driven surgery. Moderated by Philip Horner, PhD (Houston Methodist Research Institute / Weill Cornell Medicine), the discussion will explore how engineering, neuromodulation, and AI are converging to enable more precise and personalized treatments for neurological disorders.

The panelists will include:

Damiano Barone, MD, PhD,  Assistant Professor of Neurosurgery at Houston Methodist:  Dr. Barone develops next-generation flexible bioelectronic interfaces, including circumferential implants for high-resolution neural recording and stimulation.

Dimitry Sayenko, MD, PhD, Paula and Joseph C. “Rusty” Walter III Chair in Neuromodulation at Houston Methodist:  Dr. Sayenko leads pioneering work in spinal neuromodulation combined with robotic exoskeletons to restore motor function following spinal cord injury and stroke.

Lisa Gfrerer, MD, PhD, Associate Professor in Plastic and Reconstructive Surgery, Weill Cornell Medicine:  Dr. Gfrerer focuses on peripheral nerve reconstruction and has developed an AI-assisted migraine pain-mapping tool to improve surgical outcomes.

Together, these leaders will discuss how advances in neural interfaces, rehabilitation technologies, and AI-enabled clinical decision-making are shaping the future of neurologic care.

Please register here.